Detail

Study ID: ECOG-ACRIN EA5181

Title:

Randomized Phase III Trial of MEDI4736 (Durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC

Description:
NA
Location:
Bemidji Clinic, Bismarck Region, Fargo Region
Principal Investigator:
Preston Steen, MD,Preston Steen, MD,Preston Steen, MD
Disease:
Non-Small Cell Lung Cancer
Stage:
Phase III
Status:
Active - Open to Accrual